2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid has been researched along with propranolol in 1 studies
Studies (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Trials (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Recent Studies (post-2010) (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
---|---|---|---|---|---|
111 | 0 | 9 | 33,310 | 3,406 | 3,218 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C | 1 |
1 other study(ies) available for 2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and propranolol
Article | Year |
---|---|
Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Catecholamines; Epinephrine; Female; Fura-2; Humans; Hypertension; In Vitro Techniques; Isoproterenol; Lymphocytes; Magnesium; Male; Propranolol | 2004 |